NuCana plc

Pharmaceutical company · London, England, United Kingdom · Nasdaq: NCNA

NuCana plc is a pharmaceutical company headquartered in London, England, United Kingdom. Its earliest recorded incorporation is in 1997. Its shares trade on Nasdaq under the ticker NCNA. It is registered with UK Companies House under company number 03308778.

Profile compiled from public records. Is this your company? Request a correction or update

NuCana at a glance

Typepharmaceutical company

HeadquartersLondon, England, United Kingdom

Earliest incorporation on record1997

Stock listingNasdaq: NCNA

SEC industryPharmaceutical Preparations

Registered activities (UK)Research and experimental development on biotechnology

UK company number03308778

SEC CIK1709626

Frequently asked questions about NuCana

Where is NuCana headquartered?

NuCana plc is headquartered in London, England, United Kingdom.

What does NuCana do?

NuCana plc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is NuCana a public company?

Yes. NuCana plc trades on Nasdaq under the ticker NCNA.

When was NuCana founded?

The earliest incorporation on record for NuCana plc is in 1997, according to public company registers.

Similar companies

Silence Therapeutics plcLondon, England, United Kingdom
Kiniksa Pharmaceuticals International, plcLondon, England, United Kingdom
Verona Pharma plcLondon, England, United Kingdom
Mereo BioPharma Group plcLondon, England, United Kingdom
Tiziana Life Sciences LtdLondon, England, United Kingdom
Eyebiotech LtdLondon, England, United Kingdom
Realm Therapeutics plcLondon, England, United Kingdom
Autolus LimitedLondon, England, United Kingdom

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences